Dr. Reddy’s Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Financial Results:
Dr Reddys Laboratories Ltd reported Revenues for Q4FY25 of ₹8,528.00 Crores up from ₹7,114.00 Crore year on year, a rise of 19.88%.
Total Expenses for Q4FY25 of ₹7,051.00 Crores up from ₹5,710.00 Crores year on year, a rise of 23.49%.
Consolidated Net Profit of ₹1,587.00 Crores up 21.15% from ₹1,310.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹19.09, up 21.59% from ₹15.70 in the same quarter of the previous year.